A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
about
Food allergy: recent advances in pathophysiology and treatmentMonoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterizationAllergen Immunotherapy: Past, Present, and FutureTargeting the Fc receptor in autoimmune diseaseNew treatments for allergen immunotherapyIgE immunotherapy against cancerMechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.Targeting allergen to Fc gammaRI: a strategy to treat allergic disease?Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthmaExpression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas.Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.Food allergy in gastroenterologic diseases: Review of literatureDevelopment of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling."Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.Structural and immunologic cross-reactivity among filarial and mite tropomyosin: implications for the hygiene hypothesis.Tregs and allergic diseaseRegulation of mast cell responses in health and disease.Novel treatments for food allergy.A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.Emerging anti-inflammatory agents for allergic rhinitis.Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.Potential effector and immunoregulatory functions of mast cells in mucosal immunity.Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.Synovial mast cells: role in acute and chronic arthritis.The mast cell IgG receptors and their roles in tissue inflammation.Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Animal models for IgE-meditated cancer immunotherapyTargeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells.Mechanisms of sublingual immunotherapy.IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.Immunoglobulin E receptor signaling and asthmaImmunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.IgE and mast cells in allergic disease.Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice.Human Helminths and Allergic Disease: The Hygiene Hypothesis and Beyond.Histamine Release from Mast Cells and Basophils.Coaggregation of FcepsilonRI with FcgammaRIIB Inhibits Degranulation but Not Induction of Bcl-2 Family Members A1 and Bim in Mast Cells.
P2860
Q24633951-FB222A58-37A2-443B-913F-D0EA31371487Q24655389-DE672DF7-B55A-411B-B72A-051E12621A6AQ26765974-1F5C4AAA-5ACA-4EEF-9BED-EAE3D80C7D96Q27002843-F185F3C2-B1C0-480E-8A20-EB01BA2934DFQ27016089-439A14C7-8EE9-4929-863E-912B5DEC3384Q28081223-5EB60929-C7FE-46ED-BA4E-31536DF0C6ACQ30371304-01E5C4D0-C617-435A-A33C-81A1310E2491Q30437725-801F3542-8905-4622-924D-7EABC7077973Q33392541-445357DC-5B32-4452-BA8D-E368B5D74E92Q33533776-946514DC-2093-417D-A909-2181E9AA791CQ33791430-B71706A3-6AC3-4DAA-841C-29E526580F19Q33805243-42FC2D4B-46FE-4AA9-9989-C604B5D165F1Q33866661-66A42FC3-EAE9-4954-9B5F-3462AC098D6BQ33966937-7671505B-1829-42DE-ACF5-85ABC34150BDQ34647874-2DD5F14D-A3B6-4068-97CE-B4DFC6988576Q34787526-BBCDC298-A8E1-464D-BC1D-25F1ED82DB31Q35951537-0DA3E4C9-86A3-4D3F-B4C3-4653EEEC6D35Q36092456-BE777224-770E-4DBB-BC20-537D6616A5EDQ36196457-E4388D8B-5A9A-40C3-BD38-97BA10AC9DEBQ36229717-C59622C2-DA43-411C-9EAC-4EAEA1C92F13Q36302823-DCB70E57-F297-474A-A718-3B357A7A01AFQ36330511-82484CE4-A1FA-4660-89ED-04E2D6E07352Q36539857-9437B327-4CAD-4D02-9829-F746F3341D43Q36727733-2D06D1A2-1CCC-46D5-A806-B296F992F025Q36819865-3E125BA6-998F-4BA2-B972-5CB27F74F642Q36819920-EB58CAF3-7AED-4EB0-96A3-39EE54E9FD6DQ36837286-1CC3B9A7-F731-4407-B992-6C5AD32EB18DQ36970645-C3C2499E-3699-49B7-A94A-545AC61F9D7FQ37031457-C16590BB-8306-44E5-8811-2DD52260FE46Q37035553-73E66938-7045-4A33-BDC6-9403278930C3Q37502904-A2258674-E6E3-42C7-9528-F65DAE050D4DQ37554168-400A3E81-9E66-4DF4-B177-7CAC1E664D4BQ37907670-8F865F39-3817-4344-BD8F-9A9D67882E0AQ37963481-C82F94D3-475B-4D67-80AB-F8053B485EC1Q38007829-E4750BD2-F3A8-4EFA-980D-E982C1B019D3Q38345417-E43EADDD-59AF-46E7-B097-28C1FCD767E1Q38603594-DA6035CF-F42F-4173-92EC-0EA1A3F13EA9Q38940453-350F3FA3-37CA-4D1F-9097-6FA1A3FF178BQ40282553-BA8DF7E9-F97F-4085-A9E8-86222B2A426FQ40743965-C3828032-1807-4E7F-A2FB-0F27F2B75B76
P2860
A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@en
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@nl
type
label
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@en
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@nl
prefLabel
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@en
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@nl
P2093
P2860
P356
P1433
P1476
A novel human immunoglobulin F ...... lon RI-mediated degranulation.
@en
P2093
Andrew Saxon
Christopher L Kepley
Daocheng Zhu
P2860
P2888
P304
P356
10.1038/NM0502-518
P407
P577
2002-05-01T00:00:00Z